Literature DB >> 31802979

Combining Biologic Agents in Inflammatory Bowel Disease.

Maria T Abreu1.   

Abstract

Entities:  

Year:  2019        PMID： 31802979      PMCID： PMC6883734     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.

Authors:  Bruce E Sands; Jingjing Chen; Brian G Feagan; Mark Penney; William A Rees; Silvio Danese; Peter D R Higgins; Paul Newbold; Raffaella Faggioni; Kaushik Patra; Jing Li; Paul Klekotka; Chris Morehouse; Erik Pulkstenis; Jörn Drappa; René van der Merwe; Robert A Gasser
Journal:  Gastroenterology       Date:  2017-04-05       Impact factor: 22.682

Review 2.  Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders.

Authors:  Robert P Hirten; Marietta Iacucci; Shailja Shah; Subrata Ghosh; Jean-Frederic Colombel
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-02       Impact factor: 11.382

3.  Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn's Disease.

Authors:  Eddie Y Liu; Dustin E Loomes
Journal:  Case Rep Med       Date:  2017-11-08

4.  Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

Authors:  Nathaniel R West; Ahmed N Hegazy; Benjamin M J Owens; Samuel J Bullers; Bryan Linggi; Sofia Buonocore; Margherita Coccia; Dieter Görtz; Sébastien This; Krista Stockenhuber; Johanna Pott; Matthias Friedrich; Grigory Ryzhakov; Frédéric Baribaud; Carrie Brodmerkel; Constanze Cieluch; Nahid Rahman; Gerhard Müller-Newen; Raymond J Owens; Anja A Kühl; Kevin J Maloy; Scott E Plevy; Satish Keshav; Simon P L Travis; Fiona Powrie
Journal:  Nat Med       Date:  2017-04-03       Impact factor: 53.440

5.  Safety of dual biological therapy in Crohn's disease: a case series of vedolizumab in combination with other biologics.

Authors:  Eric J Mao; Sara Lewin; Jonathan P Terdiman; Kendall Beck
Journal:  BMJ Open Gastroenterol       Date:  2018-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.